Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Won Gu Kim

Showing results (201-210 of 204) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 204 results.
Oral Oncology|December 12, 2018
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort studyMijin Kim, Hye In Kim, Min Ji Jeon, et al.
Oncoimmunology|January 4, 2018
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancerHye In Kim, Mijin Kim, Se-Hoon Lee, et al.
Thyroid : Official Journal of the American Thyroid Association|December 30, 2025
Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort StudyMijin Kim, Eun Kyung Lee, Kyeong Jin Kim, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2024
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancerHye In Kim, Won Gu Kim, Mijin Kim, et al.
Pageof 21

Showing results (201-210 of 204) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 204 results.
Oral Oncology|December 12, 2018
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort studyMijin Kim, Hye In Kim, Min Ji Jeon, et al.
Oncoimmunology|January 4, 2018
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancerHye In Kim, Mijin Kim, Se-Hoon Lee, et al.
Thyroid : Official Journal of the American Thyroid Association|December 30, 2025
Thyroglobulin Cutoffs after Total Thyroidectomy Without Radioiodine in Low- to Intermediate-Risk Thyroid Cancer: A Multicenter Cohort StudyMijin Kim, Eun Kyung Lee, Kyeong Jin Kim, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2024
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancerHye In Kim, Won Gu Kim, Mijin Kim, et al.
Pageof 21